共 50 条
- [23] Is the context of R&D narrative contingent on R&D expenses or R&D intensity? Evidence from European biopharmaceutical companies [J]. EDUCATION EXCELLENCE AND INNOVATION MANAGEMENT: A 2025 VISION TO SUSTAIN ECONOMIC DEVELOPMENT DURING GLOBAL CHALLENGES, 2020, : 7626 - 7640
- [27] Foreign Acquisitions, Domestic Multinationals, and R&D [J]. SCANDINAVIAN JOURNAL OF ECONOMICS, 2014, 116 (04): : 1091 - 1115
- [29] R&D ACTIVITIES OF PHARMACEUTICAL MULTINATIONALS IN BRAZIL [J]. SISTEMAS & GESTAO, 2013, 8 (04): : 458 - 468